ResearcherGuangzhou Medical University Cancer HospitalActive in the last 2 years

Nan Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6910-4519, 0000-0002-6100-0093; OpenAlex author ID A5100341066. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper

Papers 1

Targeting MYOF suppresses pancreatic ductal adenocarcinoma progression by inhibiting ILF3-LCN2 signaling through disrupting OTUB1-mediated deubiquitination of … Last author DOI 10.1016/j.redox.2025.103665 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hongfan Liao · 1 shared paper, 2025 · strength 0.22
- Paper Targeting MYOF suppresses pancreatic ductal adenocarcinoma progression by inhibiting ILF3-LCN2 signaling through disrup… DOI 10.1016/j.redox.2025.103665 ↗
Zhihui Li · 1 shared paper, 2025 · strength 0.22
- Paper Targeting MYOF suppresses pancreatic ductal adenocarcinoma progression by inhibiting ILF3-LCN2 signaling through disrup… DOI 10.1016/j.redox.2025.103665 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.